doi.org/10.1093/annonc/mdz394.034

Randomized phase III ANGEL study of rivoceranib (apatinib) + best supportive care (BSC) vs placebo + BSC in patients with advanced/metastatic gastric cancer who failed ≥2 prior chemotherapy regimens

..., Narikazu Boku
71
Annals of Oncology65.40
Volume: 30, Pages: v877 - v878
Published: Oct 1, 2019
Paper Fields
Paper Details
Title
Randomized phase III ANGEL study of rivoceranib (apatinib) + best supportive care (BSC) vs placebo + BSC in patients with advanced/metastatic gastric cancer who failed ≥2 prior chemotherapy regimens
DOI
doi.org/10.1093/annonc/mdz394.034
Published Date
Oct 1, 2019
Journal
Annals of Oncology
Volume
30
Pages
v877 - v878
© 2025 Pluto Labs All rights reserved.